| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 20.68▲ | 20.66▲ | 20.66▲ | 20.57▲ | 21.44▼ |
| MA10 | 20.65▲ | 20.56▲ | 20.57▲ | 21.09▼ | 21.15▼ |
| MA20 | 20.55▲ | 20.52▲ | 20.53▲ | 21.49▼ | 21.07▼ |
| MA50 | 20.60▲ | 21.23▼ | 21.39▼ | 21.11▼ | 20.79▼ |
| MA100 | 21.25▼ | 21.13▼ | 21.12▼ | 20.83▼ | 19.48▲ |
| MA200 | 21.14▼ | 21.13▼ | 20.96▼ | 20.87▼ | 17.00▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.034▲ | 0.072▲ | 0.071▲ | -0.185▼ | -0.033▼ |
| RSI | 54.711▲ | 49.362▼ | 45.666▼ | 42.626▼ | 48.550▼ |
| STOCH | 59.796 | 76.791 | 71.571 | 14.152▼ | 60.184 |
| WILL %R | -33.333 | -30.693 | -25.620 | -78.596▼ | -74.669 |
| CCI | 66.975 | 87.410 | 78.591 | -67.187 | -82.029 |
| MA | $MCI Price Crossed Above MA(7) | Set Alert |
|
Tuesday, September 30, 2025 02:32 AM
Japanese drugmaker Eisai and US biotech major Biogen have presented new clinical data from a post-hoc sub-group analysis of the Clarity AD, open-label extension (OLE) study.
|
|
Monday, September 29, 2025 03:42 AM
Japanese drugmaker Eisai and US biotech major Biogen’s humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody Leqembi (lecanemab) has been approved for once every four weeks ...
|
|
Sunday, September 28, 2025 11:49 PM
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab (Leqembi) has been approved for once every four weeks intravenous (IV) maintenance dosing for the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/09/25 | 20.61 | 20.7645 | 20.4801 | 20.76 | 9,140 |
| 29/09/25 | 20.59 | 20.7794 | 20.45 | 20.60 | 14,213 |
| 26/09/25 | 20.44 | 21.07 | 20.31 | 20.73 | 20,100 |
| 25/09/25 | 20.56 | 20.85 | 20.26 | 20.44 | 23,500 |
| 24/09/25 | 20.61 | 20.90 | 20.33 | 20.34 | 16,200 |
| 23/09/25 | 20.77 | 21.12 | 20.15 | 20.45 | 47,900 |
| 22/09/25 | 21.59 | 22.11 | 20.60 | 20.68 | 105,500 |
| 19/09/25 | 22.43 | 22.56 | 21.51 | 21.60 | 60,100 |
| 18/09/25 | 22.73 | 23.00 | 22.36 | 22.43 | 18,000 |
| 17/09/25 | 22.95 | 23.00 | 22.39 | 22.84 | 44,000 |
|
|
||||
|
|
||||
|
|